Drug intelligence / Profile preview

DA-5515

Development stage
Phase 4
Lead developer
Dong-A Pharmaceutical
Administration
Oral
01

Overview

DA-5515 (Circulan) is a multi-component botanical pharmaceutical product developed by Dong-A Pharmaceutical, primarily marketed in South Korea. It is a combination of four active ingredients: Crataegus (Hawthorn) extract, Ginkgo biloba extract, Garlic oil, and Melissa officinalis (Lemon balm) extract. The formulation is designed to improve peripheral and central blood circulation. Hawthorn extract is traditionally used for its cardiotonic properties and ability to improve coronary blood flow. Ginkgo biloba extract acts as a vasodilator and inhibits platelet aggregation via antagonism of the platelet-activating factor (PAF) receptor. Garlic oil contributes to cardiovascular health by modulating lipid metabolism and providing antioxidant effects, while Lemon balm extract offers mild sedative and circulatory support. DA-5515 has been investigated in Phase 4 clinical trials for the treatment of chronic fatigue symptoms associated with impaired blood circulation.

Brand names
CirculanCirculan Soft Cap
Other names
써큐란
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)ACE (Angiotensin Converting Enzyme)PTAFR (Platelet-activating factor receptor)

Beyond the preview

Go deeper on DA-5515.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DA-5515.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call